ATE357506T1 - Flavobakterium heparinum expressions-system - Google Patents

Flavobakterium heparinum expressions-system

Info

Publication number
ATE357506T1
ATE357506T1 AT01942668T AT01942668T ATE357506T1 AT E357506 T1 ATE357506 T1 AT E357506T1 AT 01942668 T AT01942668 T AT 01942668T AT 01942668 T AT01942668 T AT 01942668T AT E357506 T1 ATE357506 T1 AT E357506T1
Authority
AT
Austria
Prior art keywords
expression system
flavobacterium heparinum
heparinum
flavobacterium
expression
Prior art date
Application number
AT01942668T
Other languages
English (en)
Inventor
Hongsheng Su
Shao Zhongqi
Ana Lydia Tkalec
Francoise Blain
Joseph Zimmerman
Original Assignee
Biomarin Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biomarin Pharm Inc filed Critical Biomarin Pharm Inc
Application granted granted Critical
Publication of ATE357506T1 publication Critical patent/ATE357506T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora

Landscapes

  • Genetics & Genomics (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Compounds Of Unknown Constitution (AREA)
AT01942668T 2000-01-21 2001-01-16 Flavobakterium heparinum expressions-system ATE357506T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US17756800P 2000-01-21 2000-01-21

Publications (1)

Publication Number Publication Date
ATE357506T1 true ATE357506T1 (de) 2007-04-15

Family

ID=22649110

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01942668T ATE357506T1 (de) 2000-01-21 2001-01-16 Flavobakterium heparinum expressions-system

Country Status (8)

Country Link
US (2) US6841375B2 (de)
EP (1) EP1252291B1 (de)
JP (1) JP2003520598A (de)
AT (1) ATE357506T1 (de)
AU (1) AU5790801A (de)
CA (1) CA2397562A1 (de)
DE (1) DE60127381D1 (de)
WO (1) WO2001053474A2 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6131811A (en) 1998-05-29 2000-10-17 E-Micro Corporation Wallet consolidator
WO2001053474A2 (en) * 2000-01-21 2001-07-26 Ibex Pharmaceuticals, Inc. Flavobacterium heparinum expression system
JP4749667B2 (ja) 2001-08-13 2011-08-17 ユニバーシティ オブ フロリダ リサーチ ファンデーション インコーポレーティッド 神経組織の修復を促進するための材料および方法
CA2493509C (en) 2002-06-03 2010-03-09 Massachusetts Institute Of Technology Rationally designed polysaccharide lyases derived from chondroitinase b
AU2003291481A1 (en) 2002-11-11 2004-06-03 Affymetrix, Inc. Methods for identifying dna copy number changes
US7767420B2 (en) * 2005-11-03 2010-08-03 Momenta Pharmaceuticals, Inc. Heparan sulfate glycosaminoglycan lyase and uses thereof
US7691612B2 (en) 2005-11-03 2010-04-06 Momenta Pharmaceuticals, Inc. Heparan sulfate glycosaminoglycan lyase and uses thereof
US7691613B2 (en) 2006-11-03 2010-04-06 Momenta Pharmaceuticals, Inc. Glycosaminoglycan lyase IV and uses thereof
US8200440B2 (en) 2007-05-18 2012-06-12 Affymetrix, Inc. System, method, and computer software product for genotype determination using probe array data

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69129899T2 (de) * 1990-12-07 1999-01-14 Kanegafuchi Kagaku Kogyo K.K., Osaka Verfahren zur Herstellung von D-Alpha-Aminosäuren
US5681733A (en) * 1994-06-10 1997-10-28 Ibex Technologies Nucleic acid sequences and expression systems for heparinase II and heparinase III derived from Flavobacterium heparinum
US6093563A (en) * 1994-07-08 2000-07-25 Ibex Technologies R And D, Inc. Chondroitin lyase enzymes
WO2001053474A2 (en) * 2000-01-21 2001-07-26 Ibex Pharmaceuticals, Inc. Flavobacterium heparinum expression system

Also Published As

Publication number Publication date
WO2001053474A8 (en) 2001-08-30
JP2003520598A (ja) 2003-07-08
CA2397562A1 (en) 2001-07-26
AU5790801A (en) 2001-07-31
EP1252291B1 (de) 2007-03-21
US20050153398A1 (en) 2005-07-14
EP1252291A2 (de) 2002-10-30
WO2001053474A3 (en) 2002-01-17
US20010034043A1 (en) 2001-10-25
WO2001053474A2 (en) 2001-07-26
US6841375B2 (en) 2005-01-11
DE60127381D1 (de) 2007-05-03

Similar Documents

Publication Publication Date Title
DK0698105T3 (da) Nukleotidsekvenser til styring af ekspressionen af DNAsekvenser i en værtscelle
GB2355459B (en) A dominant conditional lethal genetic system
BR0108396A (pt) Derivados de pirimidina-4-0na como inibidores de ldl-pla(2)
EP1476562A4 (de) Überexpression von extremozymgenen in pseudomonas und nahe verwandte bakterien
DK1210413T3 (da) Phytaseenzymer, nukleinsyrer, der koder for phytaseenzymer, og vektorer og værtsceller indeholdende de samme
DE60011100D1 (de) Als cox-hemmer verwendbare sulfonylphenylpyrazol-verbindungen
DE60127381D1 (de) Flavobakterium heparinum expressions-system
AU2003296668A1 (en) Sodium percarbonate particles with improved storage stability
DK1792982T3 (da) Codon-optimeret phosphatase og ekspression heraf i gær
ATE492631T1 (de) Verwendung von mutationen zur verbesserung von aspergillus-phytasen
DE69923676D1 (de) Bestimmte heteroaryl substituierte thiol inhibitoren von endothelin wechselnden enzymen
ATE463572T1 (de) Rekombinanter faktor viii mit erhöhter spezifischer aktivität
ATE324446T1 (de) Mutante formen von etxb und ctxb und ihre verwendung als träger
DE60031369D1 (de) Replikation -defektive baculoviren expressionssystem
DE69535316D1 (de) Als lerk6 bezeichnetes cytokin
AU2002220697A1 (en) Isolated luciferases lu164, lual and lu22, and the use of the same
DK1664102T3 (da) Isoleret photoprotein mtclytin, samt dets anvendelse
AU2001277648A1 (en) Plant cyclin-dependent kinase inhibitors
CY1111289T1 (el) Συνθεσεις αναστολεων ογκου που περιεχουν νιτροακριδινη
EP1383886A4 (de) D-hydantoinase aus ochrobactrum anthropi
DE50103225D1 (de) Wirts-vektor-systeme zur phosphatregulierten überproduktion von polypeptiden in bacillus
AU2002952143A0 (en) Use of bifunctional alpha-amylase/subtilisin inhibitor promoter to direct expression in the pericarp of plants
AU2589002A (en) Transcriptional regulator nucleic acids, polypeptides and methods of use thereof
AU2003222378A1 (en) Dna vaccine combined with an inducer of tumor cell apoptosis
DE60310708D1 (de) In vivo stabilsierung von plasmiden

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties